Unactivated C-H bonds are ubiquitous in biologically active compounds as well as intermediates in organic synthesis. Development of catalytic methods to functionalize these strong bonds selectively will offer unprecedented and efficient tools for making C-C and C-heteroatom bonds in organic synthesis and medicinal chemistry. A number of promising catalytic reactions have been developed using directed C-H activation as a key strategy. These reactions typically use pre-installed nitrogen-containing auxiliaries as directing groups via binding to metal catalysts. Considering the broad applications of auxiliaries in synthesis, auxiliaries developed for C-H insertion are not yet practical due to multiple steps and harsh conditions involved in their installation and removal. To overcome these drawbacks, we propose to develop catalytic C-H activation reactions of simple and synthetically useful carboxylic acids and amides at the 2-positions. These reactions are also applicable to simple amine derivatives. We will exploit these reactivities to develop an array of C-H activation/C-C coupling reactions using practical coupling partners such as organoboron reagents and olefins. To improve the practicality of C-H activation reactions, we propose to develop mild conditions (50-80?C and pH = 4-12) that allow the use of O2 or air as the stoichiometric oxidant. These advantages will be exploited to site-selectively functionalize biologically active natural products including dehydroabietic acid, podocarpic acid and amino acids. The structurally diversified dehydroabietic acid derivatives will be tested for potentially improved biological activity as BK channel openers. Lastly, we have also discovered an effective ligand to achieve the first Pd(II)-catalyzed enantioselective coupling of sp2 and sp3 C-H bonds with organoboronic acids which will find widespread use in synthesis and medicinal chemistry.
The C-H activation/C-C coupling reactions described in this proposal will expedite the drug discovery process by providing unprecedented routes to access biologically active compounds. The enantioselective alkylation of sp2 and sp3 C-H bonds will provide new methods for the preparation of medicinally relevant chiral molecules. Research plans for applications of these reactions in medicinal chemistry are also outlined.
|Jain, Pankaj; Verma, Pritha; Xia, Guoqin et al. (2017) Enantioselective amine ?-functionalization via palladium-catalysed C-H arylation of thioamides. Nat Chem 9:140-144|
|Chen, Gang; Zhuang, Zhe; Li, Gen-Cheng et al. (2017) Ligand-Enabled ?-C-H Arylation of ?-Amino Acids Without Installing Exogenous Directing Groups. Angew Chem Int Ed Engl 56:1506-1509|
|Zhu, Ru-Yi; Liu, Luo-Yan; Park, Han Seul et al. (2017) Versatile Alkylation of (Hetero)Aryl Iodides with Ketones via ?-C(sp3)-H Activation. J Am Chem Soc 139:16080-16083|
|Tran, Anh T; Yu, Jin-Quan (2017) Practical Alkoxythiocarbonyl Auxiliaries for Iridium(I)-Catalyzed C-H Alkylation of Azacycles. Angew Chem Int Ed Engl 56:10530-10534|
|Yang, Yun-Fang; Hong, Xin; Yu, Jin-Quan et al. (2017) Experimental-Computational Synergy for Selective Pd(II)-Catalyzed C-H Activation of Aryl and Alkyl Groups. Acc Chem Res 50:2853-2860|
|Zhu, Ru-Yi; Saint-Denis, Tyler G; Shao, Ying et al. (2017) Ligand-Enabled Pd(II)-Catalyzed Bromination and Iodination of C(sp3)-H Bonds. J Am Chem Soc 139:5724-5727|
|He, Jian; Wasa, Masayuki; Chan, Kelvin S L et al. (2017) Palladium-Catalyzed Transformations of Alkyl C-H Bonds. Chem Rev 117:8754-8786|
|Fu, Haiyan; Shen, Peng-Xiang; He, Jian et al. (2017) Ligand-Enabled Alkynylation of C(sp3 )-H Bonds with Palladium(II) Catalysts. Angew Chem Int Ed Engl 56:1873-1876|
|Liu, Tao; Qiao, Jennifer X; Poss, Michael A et al. (2017) Palladium(II)-Catalyzed Site-Selective C(sp3 )-H Alkynylation of Oligopeptides: A Linchpin Approach for Oligopeptide-Drug Conjugation. Angew Chem Int Ed Engl 56:10924-10927|
|Wu, Qing-Feng; Shen, Peng-Xiang; He, Jian et al. (2017) Formation of ?-chiral centers by asymmetric ?-C(sp3)-H arylation, alkenylation, and alkynylation. Science 355:499-503|
Showing the most recent 10 out of 71 publications